Patents by Inventor Takanori Kawaguchi
Takanori Kawaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230069963Abstract: The present invention provides a novel compound that has anti-RSV activity and that is useful in the prevention or treatment of an infection in which viruses of the subfamily Pneumovirinae, including respiratory syncytial virus (RSV), are involved, or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides a compound represented by formula (I): or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: December 24, 2019Publication date: March 9, 2023Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Takanori KAWAGUCHI, Yuya OGATA, Nozomi TANAKA, Tomoki TAKEUCHI, Toru SASAKI, Ryo TAKAHASHI, Kanako HATANAKA, Risa TSURUTA, Tomokazu TAMAOKI
-
Publication number: 20170267708Abstract: A useful novel compound that shows superior antibacterial activity also against erythromycin resistant bacteria, for example, resistant pneumococci, streptococci, mycoplasmas, and the like, against which sufficient antibacterial activity cannot be obtained with conventional macrolide antibiotics, or a pharmaceutically acceptable salt thereof, or a hydrate or a solvate thereof.Type: ApplicationFiled: August 17, 2015Publication date: September 21, 2017Applicant: TAISHO PHARMACEUTICAL CO., LTD.Inventors: Tomohiro SUGIMOTO, Masato HAYASHI, Takanori KAWAGUCHI
-
Patent number: 9695148Abstract: This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior GK-activating effect and is useful as a pharmaceutical.Type: GrantFiled: November 12, 2013Date of Patent: July 4, 2017Assignee: Nissan Chemical Industries, Ltd.Inventors: Shoichi Kuroda, Yudai Imai, Takanori Kawaguchi, Keiko Fusegi, Masahiro Bohno, Hajime Asanuma, Tomomichi Chonan, Nagaaki Sato, Souichi Monma, Shigetada Sasako, Marie Mizutani, Shin Itoh, Takumi Okada, Hirofumi Ota, Seishi Ishiyama
-
Publication number: 20160289208Abstract: This 2-pyridone compound represented by formula [1] or a tautomer of said compound, or a pharmaceutically acceptable salt of said compound or said tautomer, or a solvate of said compound or the like has a superior UK-activating effect and is useful as a pharmaceutical.Type: ApplicationFiled: November 12, 2013Publication date: October 6, 2016Applicants: TAISHO PHARMACEUTICAL CO., LTD., NISSAN CHEMICAL INDUSTRIES, LTD.Inventors: Shoichi KURODA, Yudai IMAI, Takanori KAWAGUCHI, Keiko FUSEGI, Masahiro BOHNO, Hajime ASANUMA, Tomomichi CHONAN, Nagaaki SATO, Souichi MONMA, Shigetada SASAKO, Marie MIZUTANI, Shin ITOH, Takumi OKADA, Hirofumi OTA, Seishi ISHIYAMA
-
Patent number: 8822503Abstract: A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.Type: GrantFiled: April 6, 2011Date of Patent: September 2, 2014Assignees: Taisho Pharmaceutical Co., Ltd, Nissan Chemical Industries, Ltd.Inventors: Takanori Kawaguchi, Kengo Watatani, Keiko Fusegi, Masahiro Bohno, Hajime Asanuma, Shoichi Kuroda, Yudai Imai, Tomomichi Chonan, Nagaaki Sato, Shigeru Tokita, Shigetada Sasako, Takumi Okada, Keishi Hayashi, Shin Itoh, Noriko Saito, Rui Jibiki, Seishi Ishiyama, Hirofumi Ota
-
Publication number: 20110237791Abstract: A 2-pyridone compound represented by the formula [1]: {wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.Type: ApplicationFiled: April 6, 2011Publication date: September 29, 2011Applicants: TAISHO PHARMACEUTICAL CO., LTD, NISSAN CHEMICAL INDUSTRIES, LTD.Inventors: Takanori KAWAGUCHI, Kengo WATATANI, Keiko FUSEGI, Masahiro BOHNO, Hajime ASANUMA, Shoichi KURODA, Yudai IMAI, Tomomichi CHONAN, Nagaaki SATO, Shigeru TOKITA, Shigetada SASAKO, Takumi OKADA, Keishi HAYASHI, Shin ITOH, Noriko SAITO, Rui JIBIKI, Seishi ISHIYAMA, Hirofumi OTA
-
Publication number: 20100190980Abstract: Disclosed is a pyrazinamide compound represented by the formula (1), a tautomer, stereoisomer or pharmaceutically acceptable salt thereof, or a solvate of the compound or the tautomer, stereoisomer or pharmaceutically acceptable salt thereof, which has an excellent GK-activating activity and is therefore useful as a medicinal agent. (1) wherein R1 represents a hydrogen atom, a C1-8 alkyl group, a C3-8 cycloalkyl group, a C2-9 heterocyclyl group, a phenyl group, a C1-9 heteroaryl group, a C7-14 arylalkyl group or the like; R2 represents a C1-8 alkyl group, a C2-9 heterocyclyl group, a phenyl group, a C1-9 heteroaryl group or the like; Ar represents a monocyclic or fused polycyclic C1-9 heteroaryl group represented by the formula (2) or a C2-9 heterocyclyl group represented by formula (2); Y represents —S—, —O— or —NH—; and Z represents —S—, —O— or —CH2—.Type: ApplicationFiled: June 20, 2008Publication date: July 29, 2010Applicants: Taisho Pharmaceutical Co., Ltd, Nissan Chemical Industries, LtdInventors: Hiroki Umemiya, Kengo Watatani, Takanori Kawaguchi, Kenichi Kawabe, Takumi Okada, Shigetada Sasako, Noriko Saito